Wright Medical Group reported $117.7 million in sales in the third quarter, a 6 percent increase over the same period last year.
The company said third-quarter sales of extremity products rose 18 percent, hip device revenue rose 7 percent and knee revenue grew 5 percent, but revenue from biologic products fell by 4 percent.
Read the release on Wright Medical Group's third-quarter sales.
The company said third-quarter sales of extremity products rose 18 percent, hip device revenue rose 7 percent and knee revenue grew 5 percent, but revenue from biologic products fell by 4 percent.
Read the release on Wright Medical Group's third-quarter sales.